ArticleEcancermedicalscience2020

Metronomic oral vinorelbine in patients with advanced non-small cell lung cancer progressing after nivolumab immunotherapy: a retrospective analysis.

Vittorio Gebbia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.